A 2026 review finds that combining cardiac-specific biomarkers, multimodal imaging and clinical risk factors may help ...
In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results